Cargando…

Trends in tuberculosis clinicians’ adoption of short-course regimens for latent tuberculosis infection

OBJECTIVE: Little is known about regimen choice for latent tuberculosis infection in the United States. Since 2011, the Centers for Disease Control and Prevention has recommended shorter regimens—12 weeks of isoniazid and rifapentine or 4 months of rifampin—because they have similar efficacy, better...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Pei-Jean I., Horne, David J., Wortham, Jonathan M., Katz, Dolly J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320582/ https://www.ncbi.nlm.nih.gov/pubmed/37416302 http://dx.doi.org/10.1016/j.jctube.2023.100382

Ejemplares similares

Impact of Choice of Test for Latent Tuberculosis Infection on Treatment Acceptance and Completion
por: Lambert, Lauren A, et al.
Publicado: (2018)

Short-Course Regimen for Multidrug-Resistant Tuberculosis: A Decade of Evidence
por: Trébucq, Arnaud, et al.
Publicado: (2019)

Efficacy of directly observed treatment short-course intermittent regimen in spinal tuberculosis
por: Valsalan, Rejith, et al.
Publicado: (2012)

What’s Next for the Standard Short-Course Regimen for Treatment of Multidrug-Resistant Tuberculosis
por: Campbell, Jonathon R., et al.
Publicado: (2019)

An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study
por: Surey, J., et al.
Publicado: (2021)

Course of Adverse Events during Short Treatment Regimen in Patients with Rifampicin-Resistant Tuberculosis in Burundi
por: Ciza, François, et al.
Publicado: (2020)

Tuberculosis Infection and Latent Tuberculosis
por: Lee, Seung Heon
Publicado: (2016)

Latent tuberculosis
por: Koul, Ajaz Nabi
Publicado: (2016)

Latent tuberculosis infection treatment completion in Biscay: differences between regimens and monitoring approaches
por: Ortiz Laza, N., et al.
Publicado: (2023)

Global trends and gaps in research related to latent tuberculosis infection
por: Chaw, Liling, et al.
Publicado: (2020)

Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan
por: Horter, Shona, et al.
Publicado: (2020)

The Treatment of Latent Tuberculosis
Publicado: (1905)

Latent tuberculosis infection and tuberculosis in children and adolescents
por: Ishikawa, Cassia Satsuki, et al.
Publicado: (2018)

Anatomic and Cellular Niches for Mycobacterium tuberculosis in Latent Tuberculosis Infection
por: Mayito, Jonathan, et al.
Publicado: (2019)

The ongoing challenge of latent tuberculosis
por: Esmail, H., et al.
Publicado: (2014)

Latent Tuberculosis Infection and the Risk of Subsequent Cancer
por: Su, Vincent Yi-Fong, et al.
Publicado: (2016)

Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial
por: Zheng, Xubin, et al.
Publicado: (2023)

Tuberculosis Schemes—Administrator and Clinician
por: Macgregor, A. S. M.
Publicado: (1932)

Long-term impact of the adoption of bedaquiline-containing regimens on the burden of drug-resistant tuberculosis in China
por: Agnarson, Abela Mpobela, et al.
Publicado: (2020)

Potential Economic Viability of Two Proposed Rifapentine-Based Regimens for Treatment of Latent Tuberculosis Infection
por: Holland, David P., et al.
Publicado: (2011)

Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection
por: Borisov, Andrey S., et al.
Publicado: (2018)

Screening for latent tuberculosis: the way forward for tuberculosis elimination
por: Petersen, Eskild, et al.
Publicado: (2022)

Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling
por: Knight, Gwenan M, et al.
Publicado: (2019)

Association of Mycobacterium tuberculosis infection test results with risk factors for tuberculosis transmission
por: Venkatappa, Thara, et al.
Publicado: (2023)

Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis
por: Sweeney, Sedona, et al.
Publicado: (2022)

Clinical response of newly diagnosed HIV seropositive & seronegative pulmonary tuberculosis patients with the RNTCP Short Course regimen in Pune, India
por: Tripathy, S., et al.
Publicado: (2011)

Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan
por: Horter, Shona, et al.
Publicado: (2020)

A cross-sectional study of latent tuberculosis infection, insurance coverage, and usual sources of health care among non-US-born persons in the United States
por: Annan, Esther, et al.
Publicado: (2021)

Host transcription in active and latent tuberculosis
por: Fortune, Sarah M, et al.
Publicado: (2010)

Treatment of Latent Tuberculosis Infection
por: Tang, Patrick, et al.
Publicado: (2017)

Immune Subtyping in Latent Tuberculosis
por: Banerjee, Ushashi, et al.
Publicado: (2021)

Latent Tuberculosis in India: An Overview
por: Vishwakarma, Deepak, et al.
Publicado: (2023)

Evaluating the effect of short-course rifapentine-based regimens with or without enhanced behaviour-targeted treatment support on adherence and completion of treatment for latent tuberculosis infection among adults in the UK (RID-TB: Treat): protocol for an open-label, multicentre, randomised controlled trial
por: Rangaka, Molebogeng X, et al.
Publicado: (2022)

Diagnosing Latent Tuberculosis Infection in the HIV Era
por: Lagrange, Philippe H, et al.
Publicado: (2008)

Clinical and genomic responses to ultra-short course chemotherapy in spinal tuberculosis
por: Niu, Ningkui, et al.
Publicado: (2017)

Impacts of 12-dose regimen for latent tuberculosis infection: Treatment completion rate and cost-effectiveness in Taiwan
por: Huang, Yi-Wen, et al.
Publicado: (2016)

1403. Facilitators and barriers to latent tuberculosis infection diagnosis and care in Massachusetts: a convergent mixed methods study of clinicians
por: Campbell, Jeffrey, et al.
Publicado: (2022)

Population-Level Impact of Shorter-Course Regimens for Tuberculosis: A Model-Based Analysis
por: Fofana, Mariam O., et al.
Publicado: (2014)

Guidelines on controlling latent tuberculosis infection to support tuberculosis elimination
por: Godoy, P
Publicado: (2021)

Pro-Inflammatory Alterations of Circulating Monocytes in Latent Tuberculosis Infection
por: Feria, Manuel G, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a2a6jll3jfbnprq10h07be0drl